Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

3 Stocks for Retirees in the 21st Century
3 Stocks for Retirees in the 21st Century
Though retiring from a career is a common goal for most Americans, we never quite retire from the investment landscape. After all, longevity data from the Centers for Disease Control and....
3 Stocks for Retirees in the 21st Century
3 Stocks for Retirees in the 21st Century
Though retiring from a career is a common goal for most Americans, we never quite retire from the investment landscape. After all, longevity data from the Centers for Disease Control and....
3 Stocks for Retirees in the 21st Century
3 Stocks for Retirees in the 21st Century
Though retiring from a career is a common goal for most Americans, we never quite retire from the investment landscape. After all, longevity data from the Centers for Disease Control and....
What Investors Need to Know From AutoZone, Inc.'s 4th quarter
What Investors Need to Know From AutoZone, Inc.'s 4th quarter
The market had a tough time digesting AutoZone, Inc.'s (NYSE: AZO) fourth-quarter earnings result Tuesday. Initially,after management released results, the market sent shares up roughly 4% before....
What Investors Need to Know From AutoZone, Inc.'s 4th quarter
What Investors Need to Know From AutoZone, Inc.'s 4th quarter
The market had a tough time digesting AutoZone, Inc.'s (NYSE: AZO) fourth-quarter earnings result Tuesday. Initially,after management released results, the market sent shares up roughly 4% before....
What Investors Need to Know From AutoZone, Inc.'s 4th quarter
What Investors Need to Know From AutoZone, Inc.'s 4th quarter
The market had a tough time digesting AutoZone, Inc.'s (NYSE: AZO) fourth-quarter earnings result Tuesday. Initially,after management released results, the market sent shares up roughly 4% before....
Why Nike's Express Lane Should Matter to Investors
Why Nike's Express Lane Should Matter to Investors
Global athletic apparel giant, Nike (NYSE: NKE), is re-engineering its product design and delivery processes to make them faster. This new initiative is called "express lane", and it serves as a....
Why Nike's Express Lane Should Matter to Investors
Why Nike's Express Lane Should Matter to Investors
Global athletic apparel giant, Nike (NYSE: NKE), is re-engineering its product design and delivery processes to make them faster. This new initiative is called "express lane", and it serves as a....
SunPower's Future May Ride on Next-Generation Manufacturing Plant
SunPower's Future May Ride on Next-Generation Manufacturing Plant
Over the last year, SunPower Corporation (NASDAQ: SPWR) has essentially split its business into two very distinct segments. There's the power plant business that is producing P-Series solar....
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Activision Blizzard (NASDAQ: ATVI) recently published a press release touting the first-week performance of Destiny 2. However, the document contained no actual sales figures, and the only....
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Activision Blizzard (NASDAQ: ATVI) recently published a press release touting the first-week performance of Destiny 2. However, the document contained no actual sales figures, and the only....
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Should Activision Blizzard's Investors Be Worried About "Destiny 2" Sales?
Activision Blizzard (NASDAQ: ATVI) recently published a press release touting the first-week performance of Destiny 2. However, the document contained no actual sales figures, and the only....
Don't Buy the "Death of ESPN" Hype
Don't Buy the "Death of ESPN" Hype
For much of the last three years, shares of The Walt Disney Company (NYSE: DIS) have been range bound, primarily on investor fears involving the future of its flagship ESPN sports network. From a....
3 Big Biotech Stocks to Buy This Fall
3 Big Biotech Stocks to Buy This Fall
A change in season presents a good time to look for great stocks to buy. And one of the best places to look is in the biotech industry. Biotech stocks in general are trouncing the S&P 500....
3 High-Yield Dividend Giants Still Worth Owning
3 High-Yield Dividend Giants Still Worth Owning
Many investors want to have their investment portfolios generate income, either to provide more investment capital for further stock purchases or to cover regular living expenses. High-yield....
Is Plug Power, Inc. a Buy?
Is Plug Power, Inc. a Buy?
Like solar and wind power, many alternative energy advocates have touted the potential of hydrogen power for years. Investors in fuel cell companies like Plug Power (NASDAQ: PLUG) are still....
Is Plug Power, Inc. a Buy?
Is Plug Power, Inc. a Buy?
Like solar and wind power, many alternative energy advocates have touted the potential of hydrogen power for years. Investors in fuel cell companies like Plug Power (NASDAQ: PLUG) are still....
Is Plug Power, Inc. a Buy?
Is Plug Power, Inc. a Buy?
Like solar and wind power, many alternative energy advocates have touted the potential of hydrogen power for years. Investors in fuel cell companies like Plug Power (NASDAQ: PLUG) are still....
Better Buy: Freeport-McMoRan Inc vs. Vale SA
Better Buy: Freeport-McMoRan Inc vs. Vale SA
The commodity downturn that started in 2011 was tough on mining industry giants Freeport-McMoRan Inc (NYSE: FCX) and Vale SA (NYSE: VALE). Both were left bleeding red ink and forced to sell assets....
It's Time for AeroVironment to Break Up
It's Time for AeroVironment to Break Up
After years of ups and downs, AeroVironment, Inc. (NASDAQ: AVAV) appears to be firing on all cylinders. The company's drones are growing in both military and commercial applications and its....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Is Weibo's Growth Just Getting Started?
Is Weibo's Growth Just Getting Started?
Weibo (NASDAQ: WB) stock has been on a tear in 2017, with shares up roughly 160% year to date as of this writing, trading at all-time highs. With an expanding user base and ad-sales growth driving....